Arcus Biosciences, Inc. (RCUS) Social Stream
ARCUS BIOSCIENCES INC (RCUS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ARCUS BIOSCIENCES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 8 | $70 | $50 | $59.833 | $17.73 | 237.47% |
| 2021-11-17 | 8 | $70 | $48 | $58.142 | $17.73 | 227.93% |
| 2021-11-18 | 8 | $100 | $48 | $62.714 | $17.73 | 253.72% |
| 2021-11-22 | 9 | $100 | $48 | $64.857 | $17.73 | 265.8% |
| 2022-02-24 | 7 | $100.001 | $53 | $67 | $17.73 | 277.89% |
| 2022-04-12 | 7 | $100.001 | $53 | $68 | $17.73 | 283.53% |
| 2022-05-10 | 7 | $77 | $53 | $63.143 | $17.73 | 256.14% |
| 2022-05-13 | 7 | $77 | $42 | $59.571 | $17.73 | 235.99% |
| 2022-07-08 | 7 | $66 | $42 | $55.714 | $17.73 | 214.24% |
| 2022-08-04 | 7 | $60 | $36 | $50.428 | $17.73 | 184.42% |
| 2022-08-18 | 7 | $60 | $36 | $48.571 | $17.73 | 173.95% |
| 2022-08-31 | 8 | $60 | $36 | $48.875 | $17.73 | 175.66% |
| 2022-10-11 | 9 | $60 | $36 | $47.875 | $17.73 | 170.02% |
| 2022-10-14 | 8 | $60 | $36 | $45.285 | $17.73 | 155.41% |
| 2022-11-03 | 7 | $60 | $36 | $45.125 | $17.73 | 154.51% |
| 2022-11-18 | 8 | $51 | $33 | $41.75 | $17.73 | 135.48% |
| 2022-11-23 | 9 | $51 | $33 | $41.375 | $17.73 | 133.36% |
| 2022-12-20 | 9 | $51 | $24 | $40.875 | $17.73 | 130.54% |
| 2022-12-22 | 9 | $51 | $36 | $42.375 | $17.73 | 139% |
| 2023-01-09 | 9 | $51 | $36 | $42.375 | $17.73 | 139% |
| 2023-03-01 | 9 | $51 | $24 | $40.875 | $17.73 | 130.54% |
| 2023-03-02 | 9 | $51 | $23 | $40.75 | $17.73 | 129.84% |
| 2023-05-10 | 9 | $51 | $23 | $40.5 | $17.73 | 128.43% |
| 2023-05-15 | 9 | $51 | $22 | $40.375 | $17.73 | 127.72% |
| 2023-08-08 | 9 | $51 | $22 | $40.5 | $17.73 | 128.43% |
| 2023-08-21 | 9 | $51 | $21 | $40.125 | $17.73 | 126.31% |
| 2023-08-23 | 10 | $70 | $21 | $43.444 | $17.73 | 145.03% |
| 2023-08-24 | 10 | $70 | $21 | $43.777 | $17.73 | 146.91% |
| 2023-11-07 | 10 | $70 | $23 | $44 | $17.73 | 148.17% |
| 2023-11-08 | 10 | $70 | $23 | $42.888 | $17.73 | 141.9% |
| 2023-11-13 | 10 | $70 | $23 | $42.555 | $17.73 | 140.02% |
The Trend in the Analyst Price Target
RCUS's average price target has moved up $4.56 over the prior 42 months.
RCUS reports an average of 128.44% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 9 | 51 | 24 | 40.875 | 23.09 | 77.02% |
| 2023-06-02 | 9 | 51 | 22 | 40.500 | 21.01 | 92.77% |
| 2023-10-24 | 10 | 70 | 23 | 44.000 | 15.87 | 177.25% |
| 2023-11-07 | 10 | 70 | 23 | 44.000 | 16.45 | 167.48% |
| 2023-11-13 | 10 | 70 | 23 | 42.555 | 13.43 | 216.87% |
RCUS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 9 | 0 | 1 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
RCUS's average broker recommendation rating improved by 0.02 over the prior 26 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, ARCUS BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 3528.02% of them.
- RCUS has a lower variance in analysts' estimates than -2669.84% of all US stocks.
- ARCUS BIOSCIENCES INC's average analyst price target is greater than 2813.6% of Pharmaceutical Products stocks.
- In terms of how ARCUS BIOSCIENCES INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 2271.54% of that group.
In the Pharmaceutical Products industry, ZYME, HCM, and ORGO are the three stocks most similar to ARCUS BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding RCUS using the data that counts. Try POWR Ratings for free.